BioWorld neglected to include marketable long-term securitiesfor Somatix Therapy Corp. in Tuesday's earnings report. Withthat addition, the company had $22.9 million in cash orequivalents at the end of its second quarter.
Also, contrary to Wednesday's earnings report, InSite VisionInc. reported $31 million in cash at the end of its fourthquarter.
(c) 1997 American Health Consultants. All rights reserved.